Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography

• Status: Completed
• Trial end date: 2021-09-27
• Target enrollment: 0
• Participant gender: Female

Summary

our aims to investigate the effectiveness of10% Lidocaine Spray plus oral celecoxib for Pain Control During Hysterosalpingography

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aswan University Hospital
• Treatments: Celecoxib; Lidocaine

Criteria

Inclusion Criteria:

• any patient came for Hysterosalpingography

Exclusion Criteria:

• any patient has contraindication to Hysterosalpingography